However, these complex levels are increased in both mitochondria and plasma when cultured dopaminergic cells are treated with α-synuclein [6,7], indicating that neuronal Hb and α-synuclein have distinct regulatory patterns during aging and PD. This evidence concerns the gene GSTM1 and Parkinson disease.